Author

R. D. Perrone

Observed names: Perrone RD, Perrone, Ron, Ron D Perrone, Ron Perrone

Institution: Tufts Medical Center

Observed institutions: Tufts University, Tufts Medical Center

OpenAlex ID: A5043580514

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial

2017 · Emilie Cornec-Le Gall, Jaime D Blais, et al. · Nephrology Dialysis Transplantation · 44

Making an earlier diagnosis of ADPKD: implications for the treatment of hypertension.

2006 · Ron Perrone, Dana C Miskulin · PubMed · 3

Fp047potential Impact of Tolvaptan on Blood Pressure in the Tempo 3:4 Patient Population

2018 · Arlene Chapman, Oliveir Devusyt, et al. · Nephrology Dialysis Transplantation · 2

Sp262can We Further Enrich Adpkd Clinical Trials for Rapidly Progressive Patients? Application of the Propkd Score in the Tempo Trial

2016 · Emilie Cornec-Le Gall, Olivier Devuyst, et al. · Nephrology Dialysis Transplantation · 2

Sp025relationship of Adpkd Disease-related Outcomes With Rate of Total Kidney Volume Growth: Analysis From the Overture Study

2016 · Ron Gansevoort, Jaime Blais, et al. · Nephrology Dialysis Transplantation · 1

P0680a Post-hoc Analysis of Efficacy and Safety of Tolvaptan (tol) in Decreasing Rate of Renal Function Decline in Patients With Very Late-stage Autosomal Dominant Polycystic Kidney Disease (adpkd)

2020 · Vicente Torres, Ronald Gansevoort, et al. · Nephrology Dialysis Transplantation

Works count: 8

Citation count: 52

H-index: 2

I10-index: 1